Johnson & Johnson reorganizes its PR team

Johnson & Johnson (J&J) has announced a restructuring of its public affairs and corporate communications team.

The changes, first reported by MM&M sibling publication PRWeek, follow the retirement of Nancy Walker, J&J's former VP of global pharmaceutical communications, the promotion of Anthony Carter from VP corporate communications to chief diversity officer, and the March 2009 retirement of Dave Swearingen. The new team will absorb Carter and Walker's duties, as well as Swearingen's upon his retirement, according to J&J.

In an internal notice distributed on October 3, the company announced that senior communication leaders would be linked directly with stakeholder groups. Under the new organization, six VPs will report to Ray Jordan, VP of public affairs and corporate communication: Sarah Colamarino, VP, corporate communication; Jeff Leebaw, VP, corporate communication; Pat Molino, VP, public affairs and corporate citizenship; Susan Odenthal, VP, corporate communication; Craig Rothenberg, VP, corporate communication; Swearingen will retire—as mentioned—in March 2009, but will be tasked with helping to ensure an effective transition of his responsibilities.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.